標靶治療市場：按類型、應用、分銷管道和地區分類

Targeted Therapy Market, By Type, By Application, By Distribution Channel, By Geography

出版日期: 2026年06月22日 | 出版商:

Coherent Market Insights | 英文 258 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，標靶治療市場規模將達到 915.8 億美元，到 2033 年將達到 1,471 億美元。預計 2026 年至 2033 年的複合年成長率將達到 6.87%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	915.8億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	6.87%	2033年市場規模預測：	1471億美元

標靶治療可單獨使用，也可與其他化療合併使用，例如傳統化療、手術和放射線治療。它是精準醫療的基礎。標靶治療分為兩大類：小分子藥物和單株抗體。小分子藥物因其體積小，易於進入細胞，因此可用於靶向細胞內的標靶。單株抗體（也稱為治療性抗體）是在實驗室中合成的蛋白質。大多數標靶治療透過作用於促進腫瘤生長和轉移的特定蛋白質來幫助治療癌症。它們以多種方式治療癌症，例如幫助免疫系統摧毀癌細胞、抑制癌細胞增殖、阻斷促進血管生成的訊號、殺死癌細胞、將殺傷細胞的物質遞送至癌細胞以及阻斷癌症生長所需的激素。標靶治療已獲得美國食品藥物管理局(FDA) 的批准，用於治療多種類型的癌症。這為癌症治療帶來了顯著的益處，例如改變癌細胞內的蛋白質以誘導細胞死亡，或阻止新血管的形成以切斷腫瘤的血液供應。標靶治療的主要優點之一是能夠減少癌症治療的副作用，並改善治療效果。

市場動態

人們對癌症治療中先進療法的認知不斷提高，預計將加速精準腫瘤學領域的藥物研發，並推動市場成長。例如，2021年5月，美國食品藥物管理局（FDA）批准了amivantamab-vmjw作為第一個用於治療成人非小細胞肺癌的藥物。此外，市場上的領導企業正致力於拓展產品平臺，進而鞏固市場地位，進而推動市場成長。例如，生技公司Xilio Therapeutics已與默克公司達成臨床試驗合作及供應協議，共同評估其腫瘤選擇性Fc增強型抗CTLA-4單株抗體（mAb）候選藥物XTX101與KEYTRUDA合併用藥的療效。

本次調查的主要特點

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數介紹了全球標靶治療市場主要參與者的概況：公司亮點、產品系列、關鍵亮點、財務表現和策略。
本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
這份「全球標靶治療市場」報告旨在為行業內的各類相關人員提供參考，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過各種策略矩陣來簡化其決策過程，這些矩陣用於分析全球標靶治療市場。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第8章競爭情勢

熱圖分析
市佔率分析
公司簡介
- Amgen Inc.
- GlaxoSmithKline plc
- Sanofi
- Takeda Pharmaceutical Company Limited
- Merck & Co., Inc.
- Novartis AG
- Pfizer Inc.
- F. Hoffmann-La Roche Ltd
- AstraZeneca
- Seagen Inc.
- Bayer AG
- Bristol Myers Squibb
分析師意見

第9章

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI4835

Targeted Therapy Market is estimated to be valued at USD 91.58 Bn in 2026 and is expected to reach USD 147.1 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.87% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 91.58 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	6.87%	2033 Value Projection:	USD 147.1 Bn

Targeted therapy is used individually and in combination with other treatments, such as traditional or standard chemotherapy, surgery, or radiation therapy. It is the foundation of precision medicine. Targeted therapies are divided into two classes such as small molecule medicines and monoclonal antibodies. Small-molecule drugs are small enough to enter cells easily, so they are used for targets that are inside cells. Monoclonal antibodies, also known as therapeutic antibodies, are proteins produced in the lab. Most types of targeted therapies help to treat cancer by interfering with specific proteins that help tumors grow and spread throughout the body. They treat cancer in many ways such as helps the immune system destroy cancer cells, stop cancer cells from growing, stop signals that help form blood vessels, cause cancer cell death, deliver cell-killing substances to cancer cells, starve cancer of the hormones it needs to grow. Targeted therapies is approved by the U.S. Food and Drug Administration for various types of cancers. This offers significant benefits to treat the cancer such as alter proteins within cancer cells that cause those cells to die, prevent new blood vessels from forming, which cuts off blood supply to tumor, and others. One of the major advantage of targeted therapy is it helps to reduce cancer treatment-related side effects and improved outcomes.

Market Dynamics

Increase in awareness regarding the advanced therapeutics to treat cancer leads to facilitate drug development in precision oncology is likely expected to boost the growth of market. For instance, in May 2021, the U.S. Food and Drug Administration had approved Rybrevant (amivantamab-vmjw) as the first treatment for adult patients with non-small cell lung cancer. Furthermore, key players operating in the market are engaged in focusing on expanding the products pipeline and thereby strengthening the market position. This in turn to drive the growth of market. For instance, Xilio Therapeutics, a biotechnology company entered into a clinical trial collaboration and supply agreement with Merck to evaluate XTX101, Xilio's engineered tumor-selective Fc-enhanced, anti-CTLA-4 monoclonal antibody (mAb) product candidate, in combination with KEYTRUDA.

Key features of the study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global targeted therapy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, strategies
Key companies covered as a part of this study include Amgen Inc., GlaxoSmithKline plc, Sanofi, Takeda Pharmaceutical Company Limited, Merck & Co., Inc., Novartis AG, Pfizer Inc., F. Hoffmann-La Roche Ltd, AstraZeneca, Seagen Inc., Bayer AG, and Bristol Myers Squibb
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global targeted therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have an ease in decision-making through various strategy matrices used in analyzing the global targeted therapy market

Market Segmentation

By Type (Revenue, USD Bn, 2021-2033)
Small Molecule Medicines
Monoclonal Antibodies
By Application (Revenue, USD Bn, 2021-2033)
Breast Cancer
Colorectal Cancer
Leukemia
Lung Cancer
Lymphoma
Renal Cancer
Others
By Distribution Channel (Revenue, USD Bn, 2021-2033)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region (Revenue, USD Bn, 2021-2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC
- Israel
- Rest of Middle East
Africa
- South Africa
- Central Africa
- North Africa
Key Players
Amgen Inc.
GlaxoSmithKline plc
Sanofi
Takeda Pharmaceutical Company Limited
Merck & Co., Inc.
Novartis AG
Pfizer Inc.
Hoffmann-La Roche Ltd
AstraZeneca
Seagen Inc.
Bayer AG
Bristol Myers Squibb

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Application
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Key Developments
Product Approval
Collaboration/Merge/Acquisition
Regulatory Landscape
PEST Analysis
Porter's Five Forces Analysis
Epidemiology
Robust Pipeline Analysis

4. Targeted Therapy Market, By Type, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Small Molecule Medicines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Monoclonal Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)

5. Targeted Therapy Market, By Application, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Breast Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Colorectal Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Leukemia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Lung Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Lymphoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Renal Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)

6. Targeted Therapy Market, By Distribution Channel, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)

7. Targeted Therapy Market, By Region, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Billion)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Heat Map Analysis
Market Share Analysis
Company Profile
- Amgen Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- GlaxoSmithKline plc
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Sanofi
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Takeda Pharmaceutical Company Limited
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Merck & Co., Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Novartis AG
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Pfizer Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- F. Hoffmann-La Roche Ltd
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- AstraZeneca
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Seagen Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Bayer AG
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Bristol Myers Squibb
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
Analyst Views